Ausgabe Sonderheft 1/2017
Neurogenic Orthostatic Hypotension: Grand Rounds
Inhalt (12 Artikel)
Droxidopa for symptomatic neurogenic orthostatic hypotension: what can we learn?
Horacio Kaufmann
Differential diagnosis of suspected neurogenic orthostatic hypotension in a patient with Parkinson disease
Mark Lew, Daniel Kremens
Managing neurogenic orthostatic hypotension in a patient presenting with pure autonomic failure who later developed Parkinson disease
Fiona Gupta, Daniel Kremens, Steven Vernino, Beverly Karabin
Initiating droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
Daniel Claassen, Mark Lew
Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension
Fiona Gupta, Beverly Karabin, Ali Mehdirad
Adjusting droxidopa for neurogenic orthostatic hypotension in a patient with Parkinson disease
Brent P. Goodman, Daniel Claassen, Ali Mehdirad
Defining successful treatment of neurogenic orthostatic hypotension with droxidopa in a patient with multiple system atrophy
Brent P. Goodman, Fiona Gupta
Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension
Ali Mehdirad, Beverly Karabin, Fiona Gupta
Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
Daniel Kremens, Mark Lew, Daniel Claassen, Brent P. Goodman
Polypharmacy: droxidopa to treat neurogenic orthostatic hypotension in a patient with Parkinson disease and type 2 diabetes mellitus
Steven Vernino, Daniel Claassen
Managing supine hypertension in a patient with non-diabetic autonomic neuropathy receiving droxidopa for neurogenic orthostatic hypotension
Steven Vernino, Mark Lew, Daniel Kremens
Neurogenic orthostatic hypotension: the very basics
Horacio Kaufmann, Jose-Alberto Palma